Alpha 2.0

» Articles » PMID: 32220004

Intestinal Fatty Acid-binding Protein Mediates Atherosclerotic Progress Through Increasing Intestinal Inflammation and Permeability

Overview

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2020 Mar 29

PMID 32220004

Citations 18

Authors

Authors

Lulu Zhang

Fan Wang

Jiajun Wang

Yongshun Wang

Yan Fang

Affiliations

Affiliations

Soon will be listed here.

Abstract

Atherosclerosis is one of leading phenotypes of cardiovascular diseases, featured with increased vascular intima-media thickness (IMT) and unstable plaques. The interaction between gastrointestinal system and cardiovascular homeostasis is emerging as a hot topic. Therefore, the present study aimed to explore the role of an intestinal protein, intestinal fatty acid-binding protein (I-FABP/FABP2) in the atherosclerotic progress. In western diet-fed ApoE mice, FABP2 was highly expressed in intestine. Silence of intestinal Fabp2 attenuated western diet-induced atherosclerotic phenotypes, including decreasing toxic lipid accumulation, vascular fibrosis and inflammatory response. Mechanistically, intestinal Fabp2 knockdown improved intestinal permeability through increasing the expression of tight junction proteins. Meanwhile, intestinal Fabp2 knockdown mice exhibited down-regulation of intestinal inflammation in western diet-fed ApoE mice. In clinical patients, the circulating level of FABP2 was obviously increased in patients with cardiovascular disease and positively correlated with the value of carotid intima-media thickness, total cholesterol and triglyceride. In conclusion, FABP2-induced intestinal permeability could address a potential role of gastrointestinal system in the development of atherosclerosis, and targeting on intestinal FABP2 might provide a therapeutic approach to protect against atherosclerosis.

Citing Articles

Huaiyu pill alleviates inflammatory bowel disease in mice blocking toll like receptor 4/ myeloid differentiation primary response gene 88/ nuclear factor kappa B subunit 1 pathway.

Chunyan Y, Jia L, Weijie P, Weibo D J Tradit Chin Med. 2024; 44(5):916-925.

PMID: 39380222 PMC: 11462535. DOI: 10.19852/j.cnki.jtcm.20240719.001.

A study on the treatment effects of polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota.

Hao P, Yang X, Yin W, Wang X, Ling Y, Zhu M Front Vet Sci. 2024; 11:1383801.

PMID: 38601914 PMC: 11006196. DOI: 10.3389/fvets.2024.1383801.

Amelioration of Atherosclerosis by lycopene is linked to the modulation of gut microbiota dysbiosis and related gut-heart axis activation in high-fat diet-fed ApoE mice.

Tu T, Liu H, Liu Z, Liang Y, Tan C, Feng D Nutr Metab (Lond). 2023; 20(1):53.

PMID: 38041095 PMC: 10691047. DOI: 10.1186/s12986-023-00772-x.

Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis.

Lewis C, Sellak H, Sawan M, Joseph G, Darby T, VanInsberghe D FASEB Bioadv. 2023; 5(5):199-210.

PMID: 37151850 PMC: 10158626. DOI: 10.1096/fba.2022-00121.

Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites.

Zhang W, Dong X, Huang R Transl Stroke Res. 2022; 14(6):811-828.

PMID: 36279071 DOI: 10.1007/s12975-022-01096-3.

References

1.

Furuhashi M, Hotamisligil G . Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008; 7(6):489-503. PMC: 2821027. DOI: 10.1038/nrd2589. View

2.

Carrera-Bastos P, Picazo O, Fontes-Villalba M, Pareja-Galeano H, Lindeberg S, Martinez-Selles M . Serum Zonulin and Endotoxin Levels in Exceptional Longevity versus Precocious Myocardial Infarction. Aging Dis. 2018; 9(2):317-321. PMC: 5963352. DOI: 10.14336/AD.2017.0630. View

3.

Van Itallie C, Fanning A, Bridges A, Anderson J . ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell. 2009; 20(17):3930-40. PMC: 2735491. DOI: 10.1091/mbc.e09-04-0320. View

4.

Sikora M, Stec A, Chrabaszcz M, Waskiel-Burnat A, Zaremba M, Olszewska M . Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis. J Clin Med. 2019; 8(7). PMC: 6678629. DOI: 10.3390/jcm8071021. View

5.

Lau E, Marques C, Pestana D, Santoalha M, Carvalho D, Freitas P . The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity. Nutr Metab (Lond). 2016; 13:31. PMC: 4851788. DOI: 10.1186/s12986-016-0089-7. View

6.

Sandek A, Anker S, von Haehling S . The gut and intestinal bacteria in chronic heart failure. Curr Drug Metab. 2009; 10(1):22-8. DOI: 10.2174/138920009787048374. View

7.

March D, Marchbank T, Playford R, Jones A, Thatcher R, Davison G . Intestinal fatty acid-binding protein and gut permeability responses to exercise. Eur J Appl Physiol. 2017; 117(5):931-941. PMC: 5388720. DOI: 10.1007/s00421-017-3582-4. View

8.

Zhang L, Wang F, Wang J, Wang Y, Fang Y . Intestinal fatty acid-binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability. J Cell Mol Med. 2020; 24(9):5205-5212. PMC: 7205806. DOI: 10.1111/jcmm.15173. View

9.

Li J, Lin S, Vanhoutte P, Woo C, Xu A . Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice. Circulation. 2016; 133(24):2434-46. DOI: 10.1161/CIRCULATIONAHA.115.019645. View

10.

Koeth R, Wang Z, Levison B, Buffa J, Org E, Sheehy B . Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013; 19(5):576-85. PMC: 3650111. DOI: 10.1038/nm.3145. View

11.

Guthmann F, Borchers T, Wolfrum C, Wustrack T, Bartholomaus S, Spener F . Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem. 2002; 239(1-2):227-34. View

12.

van Wijck K, Wijnands K, Meesters D, Boonen B, van Loon L, Buurman W . L-citrulline improves splanchnic perfusion and reduces gut injury during exercise. Med Sci Sports Exerc. 2014; 46(11):2039-46. DOI: 10.1249/MSS.0000000000000332. View

13.

Arakawa K, Ishigami T, Nakai-Sugiyama M, Chen L, Doi H, Kino T . Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice. PLoS One. 2019; 14(6):e0218096. PMC: 6576757. DOI: 10.1371/journal.pone.0218096. View

14.

Genth-Zotz S, von Haehling S, Bolger A, Kalra P, Wensel R, Coats A . Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am J Cardiol. 2002; 90(11):1226-30. DOI: 10.1016/s0002-9149(02)02839-4. View

15.

Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, Pogorzelska J, Prokopowicz D . Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regul Pept. 2008; 147(1-3):25-8. DOI: 10.1016/j.regpep.2007.12.002. View

16.

Pendyala S, Walker J, Holt P . A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012; 142(5):1100-1101.e2. PMC: 3978718. DOI: 10.1053/j.gastro.2012.01.034. View

17.

Libby P, Bornfeldt K, Tall A . Atherosclerosis: Successes, Surprises, and Future Challenges. Circ Res. 2016; 118(4):531-4. PMC: 4762065. DOI: 10.1161/CIRCRESAHA.116.308334. View

18.

Nakashima Y, Plump A, Raines E, Breslow J, Ross R . ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994; 14(1):133-40. DOI: 10.1161/01.atv.14.1.133. View

19.

Boord J, Fazio S, Linton M . Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol. 2002; 13(2):141-7. DOI: 10.1097/00041433-200204000-00005. View

20.

Meng G, Zhou X, Wang M, Zhou L, Wang Z, Wang M . Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways. EBioMedicine. 2019; 44:656-664. PMC: 6603492. DOI: 10.1016/j.ebiom.2019.03.066. View